Browsing Tag

PRNewswire

24164 posts
Is eGFR Alone Enough to Assess Kidney Function? "Indoxyl Sulfate" Reveals Hidden Toxin Burden

Is eGFR Alone Enough to Assess Kidney Function? "Indoxyl Sulfate" Reveals Hidden Toxin Burden

Leadgene Biomedical Leverages Taiwan’s Precision IVD Capabilities to Deepen Its Southeast Asian…
Farrer Park Hospital Introduces The Edge® Multi-Port Endoscopic Surgical Robot, Expanding Patient Choice in Robotic Surgery in Singapore

Farrer Park Hospital Introduces The Edge® Multi-Port Endoscopic Surgical Robot, Expanding Patient Choice in Robotic Surgery in Singapore

SINGAPORE, Nov. 3, 2026 /PRNewswire/ — Farrer Park Hospital (FPH) today announced…
Asia Pacific Enterprise Awards 2026 Celebrates Singapore's Leading Enterprises Setting New Standards of Excellence

Asia Pacific Enterprise Awards 2026 Celebrates Singapore's Leading Enterprises Setting New Standards of Excellence

SINGAPORE, Nov. 3, 2026 /PRNewswire/ — Singapore’s distinguished enterprises have been recognized…
Xinhua Silk Road: Foreign journalists explore Yuhang's innovation-driven development

Xinhua Silk Road: Foreign journalists explore Yuhang's innovation-driven development

BEIJING, Nov. 3, 2026 /PRNewswire/ — Journalists from South Korean, Turkish, U.S.…

Finloop Becomes Industry Pioneer in HKMA's EnsembleTX, Exploring Compliant Tokenisation Applications

HONG KONG, Nov. 3, 2026 /PRNewswire/ — Finloop Finance Technology Holding Limited ("Finloop"),…

91% of companies are building their own AI tools, but fewer than half have a deliberate strategy

New Remote research across eight countries finds companies are building AI tools…
Beyondsoft Showcases Financial AI Solutions for Southeast Asian Markets at Hong Kong FinTech Week 2026

Beyondsoft Showcases Financial AI Solutions for Southeast Asian Markets at Hong Kong FinTech Week 2026

Company presents financial technology platforms and shares experience in adapting solutions for…

Laboratoires Pierre Fabre announces the approval of BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer with a BRAFV600E mutation in Singapore

New targeted treatment option now available in for adult patients with BRAFV600E…